MedPath

Home Air Quality Impact for Adults With Asthma

Conditions
Asthma
Environmental Exposure
Home Environment Related Disease
Registration Number
NCT05224076
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The purposes of this study are to determine the practicality of using home indoor air quality monitoring and a smartphone app to identify home air quality changes and how these changes affect adults with asthma.

Detailed Description

The aims of this feasibility study are: 1) determine the feasibility and usability of: (a) ecological momentary assessment (EMA) to assess self-report residential environmental exposures and asthma symptoms, (b) home monitoring of objective environmental exposures (total volatile organic compounds \[VOCs\], particulates \[PM2.5\]), and lung function (home spirometry); 2a) assess the frequency and degree of residential environmental exposures (e.g., disinfectants/cleaners, second-hand smoke) via (a) self-reported data, and (b) home monitoring objective measures, 2b) assess the level of asthma control as indicated by self-reported asthma symptoms and lung function; and 3) explore associations of self-reported and objective measures of residential environmental exposures with self-reported and objective measures of asthma control. Participants will receive an indoor air quality monitor and a home spirometer to measure VOCs, PM2.5, and forced expiratory volume percent predicted, respectively. EMA will be collected using a personal smartphone and EMA software platform. Participants' will be sent scheduled and random EMA notifications to assess asthma symptoms, environmental exposures, lung function, and mitigation strategies. After the 14-day data collection period, participants will respond to survey items related acceptability, appropriateness, and feasibility.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adults who previously participated in the online Global Covid-19 and Asthma Study, indicated willingness to be contacted for future research, and reported high use of disinfectant/cleaning products since COVID-19 (≥5 per week).
  • Current Asthma Control Test (ACT) ≤19
  • Own a smartphone
  • Have a Wi-Fi/wireless internet connection in their home.
Exclusion Criteria
  • Non-US residents
  • Non-English speaking

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Home environmental exposure to Volatile organic compoundsMeasured continuously for 14 days

Degree of home exposures to volatile organic compounds as measured by the Awair home air quality monitor

Home environmental exposure to particulate matter (PM)Measured continuously for 14 days

Degree of home exposures to PM2.5 as measured by the Awair home air quality monitor

Asthma controlAssessed daily for 14 days

Forced Expiratory Volume (FEV) Percent predicted as measured by ZEPHYRx home spirometer

Secondary Outcome Measures
NameTimeMethod
Usability of study tools14 days

Adapted System Usability Scale, 30 items assessing usability of the ZEPHYRx home spirometer, Awair home air quality monitor, and the EMA - with response options of 1= Strongly agree to 5=Strongly Disagree

Compliance with Ecological Momentary Assessment (EMA) promptsCompliance over 4-hour periods for 14 days

Frequency of responses to daily scheduled, random, and air quality triggered EMA prompts

Trial Locations

Locations (1)

Barbara J Polivka

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath